{"ok":true,"trend":{"id":415244,"platform":"news","region":"global","key":"liquid biopsies reshape precision medicine: lori brisbin, ms, mls","title":"Liquid Biopsies Reshape Precision Medicine: Lori Brisbin, MS, MLS","url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNdTJBNl9kUVFJMk1EU1JGRThkemp1bnpGbGMxNktLRVpNQ1VrbHFpVHdZLWhzcHNSd0FrUXNMLU9KVGY5YTQyUWxXUGxQV0NtTkl3dFc5b3pNRWxWejlDaUxWdGtCbVlKUGlQa25mb2djN3lHOVZveWFTd1pFOWJkR3JVcnVfYjRQRUJteURCMUZMbS1m?oc=5","first_seen":"2026-09-29T23:30:54.185861Z","last_seen":"2026-09-30T11:50:55.351445Z","last_rank":36,"peak_rank":9,"last_volume":null,"peak_volume":0,"seen_count":10,"score":0.9890625,"category_hint":"medicine","section":"health","category":"medicine","summary":"Lori Brisbin, MS, MLS, discusses how liquid biopsies are changing precision medicine. The blood-based tests, which detect tumor DNA and other biomarkers without invasive procedures, are increasingly used to diagnose cancers, guide treatment choices, and monitor disease. Commentators in managed care circles are weighing the technology's clinical benefits against questions of cost, reimbursement, and broader adoption in routine practice.","why":"Growing clinical use of liquid biopsy testing and debate over its role and cost in precision medicine are drawing attention","tone":"neutral","entities":["Lori Brisbin","American Journal of Managed Care","liquid biopsy","precision medicine"],"summarized_at":"2026-09-30T11:34:35.818987Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"AJMC","published":"Tue, 29 Sep 2026 21:07:01 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Liquid Biopsies Reshape Precision Medicine","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-09-29T23:30:54.185861Z","rank":9,"volume":null},{"captured_at":"2026-09-30T00:53:08.612983Z","rank":11,"volume":null},{"captured_at":"2026-09-30T02:15:10.036448Z","rank":16,"volume":null},{"captured_at":"2026-09-30T03:38:30.564375Z","rank":18,"volume":null},{"captured_at":"2026-09-30T05:00:36.805213Z","rank":24,"volume":null},{"captured_at":"2026-09-30T06:22:52.532462Z","rank":26,"volume":null},{"captured_at":"2026-09-30T07:44:52.582735Z","rank":30,"volume":null},{"captured_at":"2026-09-30T09:06:53.894595Z","rank":30,"volume":null},{"captured_at":"2026-09-30T10:28:53.107499Z","rank":32,"volume":null},{"captured_at":"2026-09-30T11:50:55.351445Z","rank":36,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNdTJBNl9kUVFJMk1EU1JGRThkemp1bnpGbGMxNktLRVpNQ1VrbHFpVHdZLWhzcHNSd0FrUXNMLU9KVGY5YTQyUWxXUGxQV0NtTkl3dFc5b3pNRWxWejlDaUxWdGtCbVlKUGlQa25mb2djN3lHOVZveWFTd1pFOWJkR3JVcnVfYjRQRUJteURCMUZMbS1m?oc=5","author":"American Journal of Managed Care","title":"Liquid Biopsies Reshape Precision Medicine: Lori Brisbin, MS, MLS","snippet":null,"posted_at":"2026-09-29T21:07:01Z","likes":null}],"elsewhere":[],"window":"7d"}}